CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858)-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Delisting notice
- 8-K Event Results of operations · Regulation FD disclosure
- 10-K Report Annual Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- D/A Other Amended Notice of Exempt Offering of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- D Other Notice of Sales of Unregistered Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 196,851 shares (grant or award)
- 4 Grant or award SVP, CFO acquired 78,741 shares (grant or award)
- 4 Grant or award President, CEO and Chairman acquired 787,402 shares (grant or award)
- 4 Grant or award Director acquired 78,741 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale · Other events
Page 6 of 19 · 373 filings